Global Antibody Market Research Report 2021

Global Antibody Market Research Report 2021

Table of Contents
1 Antibody Market Overview
1.1 Product Overview and Scope of Antibody
1.2 Antibody Segment by Type
1.2.1 Global Antibody Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Antibody Sales Comparison by Application: (2021-2027)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Antibody Market Size Estimates and Forecasts
1.4.1 Global Antibody Revenue 2016-2027
1.4.2 Global Antibody Sales 2016-2027
1.4.3 Antibody Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibody Market Competition by Manufacturers
2.1 Global Antibody Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibody Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibody Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibody Manufacturing Sites, Area Served, Product Type
2.5 Antibody Market Competitive Situation and Trends
2.5.1 Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibody Players Market Share by Revenue
2.5.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody Retrospective Market Scenario by Region
3.1 Global Antibody Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Antibody Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Antibody Market Facts & Figures by Country
3.3.1 North America Antibody Sales by Country
3.3.2 North America Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antibody Market Facts & Figures by Country
3.4.1 Europe Antibody Sales by Country
3.4.2 Europe Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Antibody Sales by Region
3.5.2 Asia Pacific Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antibody Market Facts & Figures by Country
3.6.1 Latin America Antibody Sales by Country
3.6.2 Latin America Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibody Sales by Country
3.7.2 Middle East and Africa Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antibody Historic Market Analysis by Type
4.1 Global Antibody Sales Market Share by Type (2016-2021)
4.2 Global Antibody Revenue Market Share by Type (2016-2021)
4.3 Global Antibody Price by Type (2016-2021)
5 Global Antibody Historic Market Analysis by Application
5.1 Global Antibody Sales Market Share by Application (2016-2021)
5.2 Global Antibody Revenue Market Share by Application (2016-2021)
5.3 Global Antibody Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Antibody Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AbbVie Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Amgen Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antibody Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bayer Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lilly Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bristol-Myers Squibb Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Antibody Description and Business Overview
6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GlaxoSmithKline Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Antibody Description and Business Overview
6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Biogen Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Antibody Description and Business Overview
6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2016-2021)
6.13.4 AstraZeneca Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Antibody Description and Business Overview
6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Sanofi Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Antibody Description and Business Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Alexion Pharmaceuticals Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Antibody Description and Business Overview
6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Seattle Genetics Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Antibody Manufacturing Cost Analysis
7.1 Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibody
7.4 Antibody Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibody Distributors List
8.3 Antibody Customers
9 Antibody Market Dynamics
9.1 Antibody Industry Trends
9.2 Antibody Growth Drivers
9.3 Antibody Market Challenges
9.4 Antibody Market Restraints
10 Global Market Forecast
10.1 Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibody by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibody by Type (2022-2027)
10.2 Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibody by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibody by Application (2022-2027)
10.3 Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibody by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibody by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibody Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibody Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Antibody Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibody Covered in This Study
Table 5. Global Antibody Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Antibody Sales Share by Manufacturers (2016-2021)
Table 7. Global Antibody Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibody Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibody Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Antibody Product Type
Table 12. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibody Sales by Region (2016-2021) & (MT)
Table 16. Global Antibody Sales Market Share by Region (2016-2021)
Table 17. Global Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibody Sales by Country (2016-2021) & (MT)
Table 19. North America Antibody Sales Market Share by Country (2016-2021)
Table 20. North America Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibody Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibody Sales by Country (2016-2021) & (MT)
Table 23. Europe Antibody Sales Market Share by Country (2016-2021)
Table 24. Europe Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibody Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibody Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Antibody Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibody Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibody Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibody Sales by Country (2016-2021) & (MT)
Table 31. Latin America Antibody Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibody Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibody Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Antibody Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibody Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibody Revenue Market Share by Country (2016-2021)
Table 38. Global Antibody Sales (MT) by Type (2016-2021)
Table 39. Global Antibody Sales Market Share by Type (2016-2021)
Table 40. Global Antibody Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibody Revenue Share by Type (2016-2021)
Table 42. Global Antibody Price (USD/MT) by Type (2016-2021)
Table 43. Global Antibody Sales (MT) by Application (2016-2021)
Table 44. Global Antibody Sales Market Share by Application (2016-2021)
Table 45. Global Antibody Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibody Revenue Share by Application (2016-2021)
Table 47. Global Antibody Price (USD/MT) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. Roche Antibody Product
Table 52. Roche Recent Developments/Updates
Table 53. Johnson & Johnson Corporation Information
Table 54. Johnson & Johnson Description and Business Overview
Table 55. Johnson & Johnson Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Johnson & Johnson Antibody Product
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Merck Antibody Product
Table 62. Merck Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Novartis Antibody Product
Table 67. Novartis Recent Developments/Updates
Table 68. AbbVie Corporation Information
Table 69. AbbVie Description and Business Overview
Table 70. AbbVie Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. AbbVie Antibody Product
Table 72. AbbVie Recent Developments/Updates
Table 73. Amgen Corporation Information
Table 74. Amgen Description and Business Overview
Table 75. Amgen Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. Amgen Antibody Product
Table 77. Amgen Recent Developments/Updates
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Pfizer Antibody Product
Table 82. Pfizer Recent Developments/Updates
Table 83. Bayer Corporation Information
Table 84. Bayer Description and Business Overview
Table 85. Bayer Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Bayer Antibody Product
Table 87. Bayer Recent Developments/Updates
Table 88. Lilly Corporation Information
Table 89. Lilly Description and Business Overview
Table 90. Lilly Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Lilly Antibody Product
Table 92. Lilly Recent Developments/Updates
Table 93. Bristol-Myers Squibb Corporation Information
Table 94. Bristol-Myers Squibb Description and Business Overview
Table 95. Bristol-Myers Squibb Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Bristol-Myers Squibb Antibody Product
Table 97. Bristol-Myers Squibb Recent Developments/Updates
Table 98. GlaxoSmithKline Corporation Information
Table 99. GlaxoSmithKline Description and Business Overview
Table 100. GlaxoSmithKline Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. GlaxoSmithKline Antibody Product
Table 102. GlaxoSmithKline Recent Developments/Updates
Table 103. Biogen Corporation Information
Table 104. Biogen Description and Business Overview
Table 105. Biogen Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Biogen Antibody Product
Table 107. Biogen Recent Developments/Updates
Table 108. AstraZeneca Corporation Information
Table 109. AstraZeneca Description and Business Overview
Table 110. AstraZeneca Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 111. AstraZeneca Antibody Product
Table 112. AstraZeneca Recent Developments/Updates
Table 113. Sanofi Corporation Information
Table 114. Sanofi Description and Business Overview
Table 115. Sanofi Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 116. Sanofi Antibody Product
Table 117. Sanofi Recent Developments/Updates
Table 118. Alexion Pharmaceuticals Corporation Information
Table 119. Alexion Pharmaceuticals Description and Business Overview
Table 120. Alexion Pharmaceuticals Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 121. Alexion Pharmaceuticals Antibody Product
Table 122. Alexion Pharmaceuticals Recent Developments/Updates
Table 123. Seattle Genetics Corporation Information
Table 124. Seattle Genetics Description and Business Overview
Table 125. Seattle Genetics Antibody Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 126. Seattle Genetics Antibody Product
Table 127. Seattle Genetics Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Antibody Distributors List
Table 131. Antibody Customers List
Table 132. Antibody Market Trends
Table 133. Antibody Growth Drivers
Table 134. Antibody Market Restraints
Table 135. Global Antibody Sales Forecast by Type (2022-2027) & (MT)
Table 136. Global Antibody Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Antibody Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Antibody Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Antibody Sales Forecast by Application (2022-2027) & (MT)
Table 140. Global Antibody Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Antibody Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Antibody Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Antibody Sales Forecast by Region (2022-2027) & (MT)
Table 144. Global Antibody Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Antibody Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Antibody Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antibody
Figure 2. Global Antibody Market Share by Type in 2020 & 2027
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. IgA Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antibody Market Share by Application in 2020 & 2027
Figure 8. Therapeutic
Figure 9. Research
Figure 10. Diagnostic
Figure 11. Global Antibody Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antibody Market Size 2016-2027 (US$ Million)
Figure 13. Global Antibody Sales 2016-2027 (MT)
Figure 14. Global Antibody Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Antibody Sales Share by Manufacturers in 2020
Figure 16. Global Antibody Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Antibody Players: Market Share by Revenue in 2020
Figure 18. Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Antibody Sales Market Share by Region (2016-2021)
Figure 20. Global Antibody Sales Market Share by Region in 2020
Figure 21. Global Antibody Revenue Market Share by Region (2016-2021)
Figure 22. Global Antibody Revenue Market Share by Region in 2020
Figure 23. U.S. Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Antibody Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Antibody by Type (2016-2021)
Figure 48. Sales Market Share of Antibody by Application (2016-2021)
Figure 49. Sales Market Share of Antibody by Application in 2020
Figure 50. Revenue Share of Antibody by Application (2016-2021)
Figure 51. Revenue Share of Antibody by Application in 2020
Figure 52. Manufacturing Cost Structure of Antibody
Figure 53. Manufacturing Process Analysis of Antibody
Figure 54. Antibody Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antibody Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Antibody Production Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121

Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......

Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......

Global Antibody Production Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117

Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......

Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028

Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165

Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......

Monoclonal Antibody Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92

This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......

Monoclonal Antibody Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73

This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......

Monoclonal Antibody Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs